Health Disparities

Health disparities have the largest impact on the access, quality of care and outcomes overall in many patient populations defined by factors such as race, ethnicity, gender, education level, income, disability, geographic location. Many other factors also play a role, including if a patient is in a rural of urban location, distances to hospitals, pharmacies and clinics. These factors of inequitable access or healthcare are often directly related to the historical and ongoing unequal distribution of social, political, economic, and environmental resources. This page includes content defining health disparities and efforts to address them.
FDA Commissioner Robert Califf, MD, a cardiologist, speaking at the TCT interventional cardiology conference on health disparities in the U.S. health system and paying more for care has not resulted in better outcomes. #healthdisparities #healthequity

FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system

FDA Commissioner Robert Califf, MD, talked to Cardiovascular Business about healthcare spending, inconsistent patient outcomes and much more.

Jobs hiring talent people human resources

Cardiothoracic surgery linked to a lack of diversity, uneven salaries: What can be done?

A brand new analysis explored diversity, equity and inclusion within the specialty of cardiovascular surgery. It also included several recommendations for leaders looking to help create change and improve patient care.

artificial intelligence AI heart cardiology

Medtronic using AI to identify more TAVR patients in need

Medtronic has launched new research into AI's potential to identify patients with severe aortic stenosis and other worrying symptoms. The company hopes to overcome longstanding health disparities and reach individuals who may otherwise go untreated.

Video interview with Elizabeth Ann Ignacio, MD, FSIR, FACR., chair of the Society of Interventional Radiology (SIR) Small and Rural Practices Committee and president of the Hawaii Medical Association, who explains the challenges facing rural healthcare providers and the key reasons for burnout.

Interventional radiologist burnout and retention in rural areas largely related to administrative burdens

"A significant part of burnout stems from the overwhelming administrative burden," explains Elizabeth Ann Ignacio, MD, FSIR, FACR, chair of the SIR Small and Rural Practices Committee.

Video interview with Pedro Martinez Clark, MD, an interventional cardiologist, who explains how he overcame some key health disparities in Miami to make sure minority patients in low-income neighborhoods could receive screenings and care for peripheral artery disease (PAD).

Miami cardiologist works to reach more PAD patients in low-income neighborhoods

Pedro Martinez-Clark, MD, an interventional cardiologist and founder of Amavita Heart and Vascular Health, explains the health disparities he encounters that block the delivery of care in certain parts of Miami.

Anne Kroman, DO, MUSC, explains efforts to increasing female representation in electrophysiology. #GLOWE #HRS #HRS24 #WomeninEP

Efforts to get more women involved in electrophysiology and why it is important

Anne Kroman, DO, PhD, assistant professor at Medical University of South Carolina (MUSC), explains mentoring efforts for women in EP and why it is important for patients to see more female electrophysiologists to help overcome barriers.

CDC-funded program improved cardiovascular health of low-income Nebraska women

The WISEWOMAN program proved to be a useful intervention to screen low-income, uninsured women and offer them risk reduction counseling to improve blood pressure, diet and physical activity.

physician tracking patient data and reporting on outcomes

Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes

Healthcare's ongoing shift toward value-based care is a good thing, Joynt Maddox explained, but its implementation has been far from ideal. She also discussed population health, the pandemic, health disparities and the rising influence of private equity investments.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.